Compounds > levodopa

Page last updated: 2024-08-17

levodopa and Prostatic Neoplasms

levodopa has been researched along with Prostatic Neoplasms in 9 studies

Research

Studies (9)

Timeframe	Studies, this research(%)	All Research%
pre-1990	4 (44.44)	18.7374
1990's	0 (0.00)	18.2507
2000's	4 (44.44)	29.6817
2010's	1 (11.11)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Aho, V; Christopher, S; Ellmén, J; Haukka, J; Hoti, F; Korhonen, P; Kuoppamäki, M; Prami, T; Pukkala, E; Vahteristo, M	1
Brusa, L; Finazzi Agrò, E; Iani, C; Koch, G; Lo Gerfo, E; Petta, F; Sciobica, F; Stanzione, P; Torriero, S	1
Ablin, R; Bush, I; Guinan, P; Razvi, M; Sadoughi, N	1
Esposito, P; Mohr, M; Stilhart, B; Talmant, V; Tranchant, C	1
Casu, M; Lissoni, P; Mandalà, M; Rocco, F; Rovelli, F; Scardino, E; Tancini, G	1
Bordin, V; Bukovec, R; Casu, M; Egardi, R; Fumagalli, E; Gardani, G; Lissoni, P; Malugani, F; Mengo, S	1
Morales, A; Plumpton, K	1
Farnsworth, WE; Gonder, MJ	1
Tolis, GJ	1

Trials

1 trial(s) available for levodopa and Prostatic Neoplasms

Article	Year
Effect of bicalutamide therapy on prolactin response to L-dopa in metastatic prostate cancer patients. Neuro endocrinology letters, 2002, Volume: 23, Issue:1 Topics: Aged; Androgen Antagonists; Anilides; Humans; Levodopa; Male; Middle Aged; Nitriles; Prolactin; Prostatic Neoplasms; Tosyl Compounds	2002

Other Studies

8 other study(ies) available for levodopa and Prostatic Neoplasms

Article	Year
Entacapone and prostate cancer risk in patients with Parkinson's disease. Movement disorders : official journal of the Movement Disorder Society, 2015, Apr-15, Volume: 30, Issue:5 Topics: Antiparkinson Agents; Catechol O-Methyltransferase Inhibitors; Catechols; Cohort Studies; Drug Therapy, Combination; Humans; Levodopa; Male; Nitriles; Parkinson Disease; Prostatic Neoplasms; Registries; Risk; Time Factors	2015
Effects of inhibitory rTMS on bladder function in Parkinson's disease patients. Movement disorders : official journal of the Movement Disorder Society, 2009, Feb-15, Volume: 24, Issue:3 Topics: Aged; Antiparkinson Agents; Female; Humans; Levodopa; Male; Middle Aged; Parkinson Disease; Prostatic Neoplasms; Severity of Illness Index; Surveys and Questionnaires; Time Factors; Transcranial Magnetic Stimulation; Urinary Bladder, Overactive; Urodynamics	2009
Cancer of prostate: relief of bone pain with levodopa. Urology, 1974, Volume: 4, Issue:1 Topics: Bone Neoplasms; Humans; Levodopa; Male; Pain; Prostatic Neoplasms	1974
[Subthalamic stimulation in a patient with multiple system atrophy: a clinicopathological report]. Revue neurologique, 2006, Volume: 162, Issue:3 Topics: Adenoma; alpha-Synuclein; Antiparkinson Agents; Biomarkers; Brain; Brain Chemistry; Combined Modality Therapy; Deep Brain Stimulation; Diagnostic Errors; Disease Progression; Fatal Outcome; Humans; Levodopa; Magnetic Resonance Imaging; Male; Middle Aged; Multiple System Atrophy; Parkinson Disease; Prostatectomy; Prostatic Neoplasms; Substantia Nigra; Subthalamic Nucleus; Ubiquitin	2006
Paradoxical stimulation of prolactin secretion by L-dopa in metastatic prostate cancer and its possible role in prostate-cancer-related hyperprolactinemia. European urology, 2000, Volume: 37, Issue:5 Topics: Aged; Humans; Hyperprolactinemia; Levodopa; Male; Metoclopramide; Middle Aged; Neoplasm Metastasis; Prolactin; Prostatic Neoplasms	2000
Letter: Levodopa in cancer of the prostate. The Journal of urology, 1975, Volume: 114, Issue:3 Topics: Bone Neoplasms; Humans; Levodopa; Male; Neoplasm Metastasis; Palliative Care; Prostatic Neoplasms	1975
Prolaction and prostate cancer. Urology, 1977, Volume: 10, Issue:1 Topics: Bone Neoplasms; Humans; Levodopa; Male; Neoplasm Metastasis; Prostatic Neoplasms; Remission, Spontaneous	1977
Letter: L-dopa for pain from bone metastases (cont.). The New England journal of medicine, 1975, 06-19, Volume: 292, Issue:25 Topics: Bone Neoplasms; Breast Neoplasms; Female; Humans; Levodopa; Male; Neoplasm Metastasis; Pain; Prostatic Neoplasms	1975